Aptose Biosciences Inc. (formerly Lorus Therapeutics Inc.)
|
(Name of Issuer)
|
Common Stock
|
(Title of Class of Securities)
|
03835T101 (formerly 544192107)
|
(CUSIP Number)
|
Herbert Abramson
22 St. Clair Avenue East, 18th Floor
Toronto, Ontario, Canada
M4T 2S3
(416) 361-1498
|
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
|
October 14, 2014
|
(Date of Event which Requires Filing of this Statement)
|
*
|
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
|
1 |
NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
Technifund Inc.
I.R.S. Identification No. -- Not Applicable
|
||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) x |
||
3 |
SEC Use Only
|
||
4 |
SOURCE OF FUNDS
WC
|
||
5 |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
o
|
||
6 | CITIZENSHIP OR PLACE OF ORGANIZATION
Ontario, Canada
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7 |
SOLE VOTING POWER
86,110
|
|
8 | SHARED VOTING POWER
|
||
9 | SOLE DISPOSITIVE POWER
86,110
|
||
10 | SHARED DISPOSITIVE POWER
0
|
||
11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
86,110 *
|
||
12 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
o
|
||
13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.7% *
|
||
14 |
TYPE OF REPORTING PERSON
HC
|
1 |
NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
Herbert Abramson
I.R.S. Identification No. -- Not Applicable
|
||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) x |
||
3 |
SEC Use Only
|
||
4 |
SOURCE OF FUNDS
PF
|
||
5 |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
o
|
||
6 | CITIZENSHIP OR PLACE OF ORGANIZATION
Canadian
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7 |
SOLE VOTING POWER
742,751
|
|
8 | SHARED VOTING POWER
|
||
9 | SOLE DISPOSITIVE POWER
742,751
|
||
10 | SHARED DISPOSITIVE POWER
0
|
||
11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
742,751 *
|
||
12 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
o
|
||
13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
6.4% *
|
||
14 |
TYPE OF REPORTING PERSON
IN
|
Date of Transaction
|
Quantity
Purchased (Sold)
|
Price/Share (CDN$)
|
||||||
7/9/14
|
16,000 | $ | 0.4800 | |||||
9/23/14
|
(100,000 | ) | $ | 0.4950 | ||||
9/25/14
|
(20,000 | ) | $ | 0.4700 | ||||
10/10/14
|
1,300 | $ | 6.5096 | |||||
10/14/14
|
700 | $ | 5.9793 |
/s/ Herbert Abramson | |||
Herbert Abramson | |||
TECHNIFUND INC. | |||
By: /s/ Herbert Abramson | |||
Name: Herbert Abramson | |||
Title: President |